IRIS UniCatt

Galli, Eugenio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.865
AS - Asia 2.138
EU - Europa 2.117
SA - Sud America 391
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 54
OC - Oceania 1
Totale 7.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.752
SG - Singapore 912
CN - Cina 479
IT - Italia 441
DE - Germania 369
NL - Olanda 360
BR - Brasile 325
VN - Vietnam 249
FI - Finlandia 170
FR - Francia 169
SE - Svezia 169
PL - Polonia 152
IN - India 101
GB - Regno Unito 82
JP - Giappone 72
BD - Bangladesh 68
CA - Canada 60
IE - Irlanda 46
ID - Indonesia 45
HK - Hong Kong 41
KR - Corea 40
RU - Federazione Russa 32
MX - Messico 31
AT - Austria 23
CZ - Repubblica Ceca 23
ES - Italia 21
AR - Argentina 20
IQ - Iraq 19
SA - Arabia Saudita 17
TR - Turchia 15
BE - Belgio 13
CO - Colombia 12
EC - Ecuador 12
UZ - Uzbekistan 11
ZA - Sudafrica 11
CI - Costa d'Avorio 9
UA - Ucraina 9
JO - Giordania 8
KE - Kenya 8
MA - Marocco 8
VE - Venezuela 8
IL - Israele 7
LT - Lituania 7
PK - Pakistan 7
IR - Iran 5
AZ - Azerbaigian 4
KZ - Kazakistan 4
LB - Libano 4
NP - Nepal 4
TN - Tunisia 4
UY - Uruguay 4
BO - Bolivia 3
BY - Bielorussia 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
KG - Kirghizistan 3
KW - Kuwait 3
OM - Oman 3
PH - Filippine 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BZ - Belize 2
CH - Svizzera 2
CR - Costa Rica 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
PR - Porto Rico 2
PY - Paraguay 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
Totale 7.558
Salva come PNG Salva come JPEG
Città #
Singapore 521
San Jose 366
Amsterdam 348
Ashburn 268
Munich 152
Frankfurt am Main 147
Warsaw 145
Rome 142
Los Angeles 135
Chandler 119
Hefei 107
Helsinki 102
Beijing 93
New York 78
St Louis 76
Tokyo 71
Hanoi 70
Chicago 67
Milan 67
The Dalles 66
Lauterbourg 65
Ho Chi Minh City 64
Council Bluffs 58
Hyderabad 57
Santa Clara 45
Dublin 42
Seoul 40
Hong Kong 39
Dallas 37
Jakarta 35
Kent 34
Florence 33
Lappeenranta 33
Fairfield 31
Turku 27
Atlanta 26
London 26
Brooklyn 24
Orem 22
Phoenix 22
Seattle 22
Montreal 21
Paris 21
Toronto 21
São Paulo 20
Nuremberg 19
Boardman 18
Buffalo 17
Denver 17
Houston 17
Da Nang 16
Brno 15
Chennai 15
Moscow 15
Marseille 14
Wilmington 14
Boston 13
Bremen 13
Brussels 13
Mexico City 13
Miami 13
Woodbridge 13
Belo Horizonte 12
Düsseldorf 12
Princeton 11
Tashkent 11
Charlotte 10
Rio de Janeiro 10
San Mateo 10
Stockholm 10
Vienna 10
Abidjan 9
Haiphong 9
Manchester 9
Poplar 9
Redmond 9
Campinas 8
Falls Church 8
Guangzhou 8
Naples 8
San Francisco 8
Amman 7
Baghdad 7
Catania 7
Johannesburg 7
Nairobi 7
Shanghai 7
Tampa 7
Tukwila 7
Bogotá 6
Cambridge 6
Casablanca 6
Cattolica 6
Curitiba 6
Jeddah 6
Madrid 6
Memphis 6
New Delhi 6
Philadelphia 6
Portsmouth 6
Totale 4.563
Salva come PNG Salva come JPEG
Nome #
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 639
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 304
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 294
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 276
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 251
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 240
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 189
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 158
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 152
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 149
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 142
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 142
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 133
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 130
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 125
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 123
CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL) 122
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 121
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 120
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 118
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 118
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 118
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 116
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 112
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 112
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 112
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 112
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 111
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 110
Coagulopathy in CAR-T: Critical concern or mere blip? 109
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 108
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 108
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma 107
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 105
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 104
Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma 103
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 101
Vascular inflammation in patients undergoing anti-CD19 chimeric antigen receptor-T cells for haematologic malignancies: a call for cardiovascular surveillance 99
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 98
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 92
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 90
Prognostic factors in hodgkin lymphoma 85
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 84
G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma 83
VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation 81
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT 81
Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant 77
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 75
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 71
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 67
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma 65
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 63
Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS) 59
Cinnamon-enriched chocolate pralines as a delivery system for Lacticaseibacillus rhamnosus CRL1505: viability and digestive stability 54
is allogenic transplantation on option in patients affected by concurrent myelofibrosis and chronia myeloid leukemia (CML) 54
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? 53
Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T 48
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study 46
Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy 42
Frail is not fail: Limited impact of comorbidities on non‐relapse mortality and safety in patients with LBCL treated with CAR‐T 41
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 39
Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy 36
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 32
Clinical features and management of LICATS involving the heart in a patient with diffuse and rapidly progressive systemic sclerosis 24
Organ-specific local cytokine release syndrome after anti-CD19 CAR-T therapy with salivary gland involvement: a case report, literature review, and a diagnostic alert for tocilizumab-associated cervical swelling 20
Neuronal injury biomarkers GFAP and neurofilament light chains (NfL) are associated with neurotoxicity and endothelial dysfunction in adult patients treated with antiCD19 CART cells 19
Lymphodepletion and donor lymphocyte infusions (LD-DLI) for DLI-non responsive myelofibrosis 13
Tracking inflammation in CAR-T therapy: the emerging role of serum amyloid A (SAA) 5
Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a Real-World Setting 4
Platelet recovery delay and survival in patients with myelofibrosis undergoing allogeneic hemopoietic stem cell transplantation 4
High-dose thiotepa may induce inappropriate secretion of antidiuretic hormone syndrome (SIADH) during conditioning treatment for allogeneic stem cell transplantation 3
Deciphering the Complex Intertwining Between Cytopenia and Transfusion Needs After CAR-T-Cell Therapy for B-Cell Malignancies 2
Totale 7.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.979
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022115 0 5 1 5 13 8 2 14 6 5 24 32
2022/2023427 67 47 16 63 28 52 34 27 47 21 23 2
2023/2024398 10 71 26 39 5 50 28 38 5 35 34 57
2024/20251.768 41 30 78 169 111 95 123 79 184 165 420 273
2025/20263.860 420 139 214 335 463 642 556 200 269 312 151 159
2026/2027823 326 497 0 0 0 0 0 0 0 0 0 0
Totale 7.704